These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7559009)

  • 21. Implications for the FDA/Center for Veterinary Medicine (CVM).
    Geyer RE
    J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
    [No Abstract]   [Full Text] [Related]  

  • 22. Helpful tips for extralabel drug use: record keeping, record access, and product labels. The FDA-Center for Veterinary Medicine and the American Veterinary Medicine Association.
    J Am Vet Med Assoc; 1998 Mar; 212(5):666-7. PubMed ID: 9556375
    [No Abstract]   [Full Text] [Related]  

  • 23. Skills and competencies required by veterinary pharmacologists: a blueprint for graduate education in veterinary pharmacology in North America.
    Fajt VR
    J Vet Pharmacol Ther; 2008 Feb; 31(1):22-30. PubMed ID: 18177315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scientific basis for nonapproved use of drugs in veterinary practice.
    Brumbaugh GW
    J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
    [No Abstract]   [Full Text] [Related]  

  • 25. A historical profile of veterinary pharmacology and therapeutics.
    Ruckebusch Y
    Hist Med Vet; 1995; 20(3):49-79. PubMed ID: 11609125
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings of an International Conference on Veterinary Pharmacology, Toxicology and Therapeutics. Cambridge, Great Britain, 28 July to 1 August 1980.
    Vet Res Commun; 1983 Dec; 7(1-4):1-439. PubMed ID: 6686732
    [No Abstract]   [Full Text] [Related]  

  • 27. The issue of extralabel drug use.
    Kennedy JA
    J Am Vet Med Assoc; 1997 Dec; 211(11):1354. PubMed ID: 9394877
    [No Abstract]   [Full Text] [Related]  

  • 28. Extra-label drug use: with rights come responsibilities.
    Cleland JL
    J Am Vet Med Assoc; 1996 Sep; 209(5):897-8. PubMed ID: 8790533
    [No Abstract]   [Full Text] [Related]  

  • 29. AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Association of Avian Pathologists (AAAP).
    Wages DP
    J Am Vet Med Assoc; 1995 Oct; 207(7):880-1; discussion 890-4. PubMed ID: 7559012
    [No Abstract]   [Full Text] [Related]  

  • 30. Veterinarians and drug labels.
    Hannah HW
    J Am Vet Med Assoc; 1978 May; 172(9):1022. PubMed ID: 659317
    [No Abstract]   [Full Text] [Related]  

  • 31. Professional responsibilities.
    Jenkins WL
    J Am Vet Med Assoc; 1993 May; 202(10):1742-3. PubMed ID: 8514601
    [No Abstract]   [Full Text] [Related]  

  • 32. Veterinary compounding in small animals: a clinical pharmacologist's perspective.
    Boothe DM
    Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1129-73, viii. PubMed ID: 16984830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flexible labeling, streamlined drug approval advocated at workshop.
    Raef TA
    J Am Vet Med Assoc; 1995 Jul; 207(1):7-9. PubMed ID: 7601697
    [No Abstract]   [Full Text] [Related]  

  • 34. [The development of veterinary boards and veterinary institutes in Germany in the 18th and 19th centuries].
    Kötsche W
    Berl Munch Tierarztl Wochenschr; 1994 Feb; 107(2):55-7. PubMed ID: 7993340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra.
    Hollister AS; Kearns GL
    Clin Pharmacol Ther; 2003 Nov; 74(5):403-5. PubMed ID: 14586380
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment and reporting of clinical pharmacology information in drug labeling.
    Spyker DA; Harvey ED; Harvey BE; Harvey AM; Rumack BH; Peck CC; Atkinson AJ; Woosley RL; Abernethy DR; Cantilena LR
    Clin Pharmacol Ther; 2000 Mar; 67(3):196-200. PubMed ID: 10741621
    [No Abstract]   [Full Text] [Related]  

  • 37. The future of veterinary therapeutics: a glimpse towards 2030.
    Riviere JE
    Vet J; 2007 Nov; 174(3):462-71. PubMed ID: 17825591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology considerations regarding compounding.
    Powers TE
    J Am Vet Med Assoc; 1994 Jul; 205(2):221-3. PubMed ID: 7928581
    [No Abstract]   [Full Text] [Related]  

  • 39. Special pesticide formulations. Veterinarians must follow EPA rules.
    J Am Vet Med Assoc; 2004 Aug; 225(4):490-1. PubMed ID: 15344349
    [No Abstract]   [Full Text] [Related]  

  • 40. Questions location of new National Bio and Agro-Defense Facility.
    Kanfer D
    J Am Vet Med Assoc; 2009 Apr; 234(7):875-6. PubMed ID: 19360991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.